Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Selective attention and mismatch negativity in antipsychotic-naïve, first-episode schizophrenia patients before and after 6 months of antipsychotic monotherapy

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Neurocognitive heterogeneity in patients with bipolar disorder and their unaffected relatives: associations with emotional cognition

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra-high risk for psychosis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Attention deficits have been frequently reported in schizophrenia. It has been suggested that treatment with second-generation antipsychotics can ameliorate these deficits. In this study, the influence of 6 months treatment with quetiapine, a compound with less affinity for dopamine D2 receptors than for serotonergic 5-HT2A receptors, on electrophysiological parameters of attention was investigated in a group of antipsychotic-naïve, first-episode schizophrenia patients compared with a group of age- and gender-matched healthy controls.

METHOD: A total of 34 first-episode, antipsychotic-naïve patients with schizophrenia and an equal number of healthy controls were tested in a selective attention and a typical mismatch negativity (MMN) paradigm at baseline and after 6 months. The patients were treated with quetiapine according to their clinical needs during the period between baseline and follow-up, whereas controls received no treatment.

RESULTS: Patients showed lower MMN and P200 amplitude than healthy controls in the selective attention paradigm at baseline, while this was not the case for MMN of the typical MMN paradigm. Interestingly, after 6 months treatment, this MMN deficit was only ameliorated in patients treated with above median dosages of quetiapine. Patients had lower P3B amplitude, yet showed similar levels of processing negativity and N100 amplitude compared with healthy controls, both at baseline and follow-up.

CONCLUSIONS: The results indicate that deficits in MMN, P200 and P3B amplitude are present at early stages of schizophrenia, although depending on the paradigm used. Furthermore, the results indicate that 6 months quetiapine treatment ameliorates MMN but not P3B deficits, and only in those subjects on higher dosages.

Original languageEnglish
JournalPsychological Medicine
Volume47
Issue number12
Pages (from-to)2155-2165
Number of pages11
ISSN0033-2917
DOIs
Publication statusPublished - Sep 2017

    Research areas

  • Journal Article

ID: 51990049